Live Chat

ट्रेड BioNTech BNTX

बेचें
 खरीदें

BioNTech लाइव चार्ट

5m 15m 30m 1h 4h 1d 1w

उपकरण मूल बातें

Weekly Search
Weekly
Daily
दिनांक बंद करें परिवर्तन (%) परिवर्तित करें खुला उच्च कम

नवीनतम समाचार

Frances Wang 2024 Nov 20, 16:00

MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K

Cryptocurrencies
Frances Wang 2024 Nov 20, 16:00

Nasdaq futures decline, Nvidia shares dip following the earnings report

Indices CFD Trading Stocks
Mixed market performance
Neil Wilson 2024 Nov 20, 16:00

Markets Mixed Amid Inflation, Tech Rally, and UK Economic Woes

USD Tech S&P 500
Frances Wang 2024 Nov 19, 16:00

Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024

NVDA Stocks
Frances Wang 2024 Nov 19, 16:00

Bitcoin price hits record high over $93,800 as Trump rally resumes

Cryptocurrencies
Rising gold prices
Neil Wilson 2024 Nov 19, 16:00

Gold Shines, Bitcoin Surges, and Nvidia Earnings in Focus

Gold Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

What is the cryptocurrency market doing: Musk's DOGE Role Boosts Dogecoin

Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

Bitcoin price prediction: BTC May Reach $100K Before New Year

Cryptocurrencies

जानकारी

स्प्रेड

1.0525

स्प्रेड (%)

1.0364 %

लीवरेज

1:5

ओवरनाइट ब्याज विक्रय

-0.0597 %

overnight_interest_sell

-0.0292 %

मुद्रा

USD

ट्रेडिंग घंटे

बाज़ार बंद है

गुरुवार

14:31 - 20:59

सोमवार

14:31-20:59

मंगवार

14:31-20:59

बुधवार

14:31-20:59

शुक्रवार

14:31-20:59

विश्लेषण और सांख्यिकी

खुला

---

पिछला बंद

---

52 सप्ताह उच्च/निम्न्च

--- – ---

बाज़ार आकार

25508335616

बकाया शेयर

239740000

प्राप्ति की तिथि (आगे)

0000-00-00

लाभांश आय 

2022-06-17

पूर्व-लाभांश तिथि

2022-06-02

अग्रिम वार्षिक लाभांश दर 

0

अग्रिम वार्षिक लाभांश आय

0

EPS

-2.05

इस उपकरण के बारे में अधिक जानें

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A, as well as strategic partnership the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen africa's mrna vac

संबंधित उपकरण

संपत्ति
बेचें
खरीदें
(%) परिवर्तित करें

अब ट्रेड करें

अब ट्रेड करें

अब ट्रेड करें

अब ट्रेड करें
view_all_instruments
Trustpilot
Live Chat